InvestorsHub Logo
Followers 1
Posts 30
Boards Moderated 0
Alias Born 02/21/2021

Re: Petra5 post# 18147

Wednesday, 02/24/2021 9:21:40 PM

Wednesday, February 24, 2021 9:21:40 PM

Post# of 20017
Nothing wrong with healthy skepticism. Motivated me to do some additional searching.

If NDTP absorbed Keystone Nano, then that's 8 employees and $639k in revenue (assuming this is on annual basis, may be a large assumption, could be more or less). https://www.dnb.com/business-directory/company-profiles.keystone_nano_inc.0ad2914457bd0138bd539f18542e8295.html#:~:text=Keystone%20Nano%2C%20Inc.%20has%208,%24639%2C589%20in%20sales%20(USD).Their licensing to the tech IS the product, if i'm reading this right.

And i'm assuming Fountain kept the licensing to his patents?

Hovis is knowledgeable with bringing beverages to market. Would it be a stretch to say they have been quietly setting up distribution chains or could do so quickly? I don't think so. I imagine most new beverage companies engage existing infrastructure. You setup bottling agreements, distribution, etc. Essentially you're renting space on their lines. You give them the specs and voila. Same for pill manufacturing.

Feel free to punch holes in this theory. My guess is these guys have a war chest. Company and personal deep pocket. But maybe i'm being overly optimistic.